Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,350 shares of common stock on 05/30/2024, with an aggregate market value of approximately $1,031,908. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction from the issuer. There have been no other securities sold by Tatsis in the past three months prior to the notice date of the planned sale.